Effect of lanthanum carbonate on serum levels of calcification inhibitor fetuin-A in hemodialysis patients

Effect of lanthanum carbonate on serum levels of calcification inhibitor fetuin-A in hemodialysis patients - Effect of lanthanum carbonate on serum levels of fetuin-A in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010730

Enrollment

Registered

2013-05-15

Start date

2013-05-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

Lanthanum carbonate administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patient Hyperphosphatemia patient

Exclusion criteria

Exclusion criteria: Lanthanum carbonate contraindication After parathyroidectomy Peritoneal dialysis patient Digestive tract disease patient Liver dysfunction patient Pregnant woman

Design outcomes

Primary

Measure	Time frame
serum fetuin-A concentration	—

Secondary

Measure	Time frame
serum FGF-23 concentration safety evaluation	—

Countries

Japan

Contacts

Public ContactHideyasu Matsuyama

Yamaguchi University Hospital Department of urology

hidde@yamaguchi-u.ac.jp0836222275

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026